Catherine L Hill
Overview
Explore the profile of Catherine L Hill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
176
Citations
3897
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sweeney A, Bridgewater S, Orme J, Sattui S, Sharp M, Richards P, et al.
BMJ Open
. 2025 Feb;
15(2):e089225.
PMID: 39909511
Objectives: The Steroid PRO is a treatment-specific patient-reported outcome questionnaire which measures the impact of glucocorticoids on health-related quality of life. It has 15 items grouped into 4 domains (Social...
2.
Mau A, Keen H, Hill C, Buchbinder R
Intern Med J
. 2025 Jan;
PMID: 39754748
Background: The Australian Rheumatology Association identified the use of imaging in patients with low back pain without indication of serious pathology as a low-value practice. Aims: To determine the appropriateness...
3.
Bryant M, Black R, Hill C
Int J Rheum Dis
. 2025 Jan;
28(1):e70044.
PMID: 39754011
No abstract available.
4.
Tieu J, Cheah J, Lyne S, Yip K, Ghosh N, Richards P, et al.
Semin Arthritis Rheum
. 2024 Dec;
71:152602.
PMID: 39648085
Introduction: There is no consensus amongst patients and healthcare professionals about how to measure important adverse effects of glucocorticoids (GCs) that includes the patient's perspective. The OMERACT GC Impact working...
5.
Major T, Takei R, Matsuo H, Leask M, Sumpter N, Topless R, et al.
Nat Genet
. 2024 Nov;
56(11):2577.
PMID: 39501129
No abstract available.
6.
Hoon E, Edwards J, Robinson P, Rowett D, Stocks N, Keen H, et al.
Aust J Gen Pract
. 2024 Nov;
53(11):864-871.
PMID: 39499846
Background And Objectives: This study aimed to understand how gout is currently managed in Australian primary care and to assess the level of interest in changing the delivery of care...
7.
Russell O, Lester S, Black R, Lassere M, Barrett C, March L, et al.
Arthritis Care Res (Hoboken)
. 2024 Oct;
77(1):127-135.
PMID: 39467045
Objective: Individuals with inflammatory arthritis require long-term rheumatologist care for optimal outcomes. We sought to determine if socioeconomic status (SES) influences general practitioner (GP) and specialist physician visit frequency and...
8.
Major T, Takei R, Matsuo H, Leask M, Sumpter N, Topless R, et al.
Nat Genet
. 2024 Oct;
56(11):2392-2406.
PMID: 39406924
Gout is a chronic disease that is caused by an innate immune response to deposited monosodium urate crystals in the setting of hyperuricemia. Here, we provide insights into the molecular...
9.
Bryant M, Black R, Lester S, Chand V, Barrett C, Buchbinder R, et al.
Rheumatol Adv Pract
. 2024 Oct;
8(4):rkae099.
PMID: 39376963
Objectives: To evaluate the reliability and validity of an adapted Commissioning for Quality in Rheumatoid Arthritis-RA-Patient-Reported Experience Measure (CQRA-RA-PREM) for assessing care experience in an Australian rheumatology outpatient cohort. Methods:...
10.
Hill C, Pulver L, Liew D
Intern Med J
. 2024 Sep;
54(10):1733-1738.
PMID: 39329217
High-cost medicines (HCMs) can be clinically impactful for individual patients but are also subject to variable funding mechanisms. Public hospitals and health services are often asked to fund HCMs, but...